ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI awards center Grant to Cancer Institute of New Jersey; Researcher Win Honors

April 4, 1997

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014